428 related articles for article (PubMed ID: 26391167)
1. Intravitreal anti-VEGF therapy for macular radiation retinopathy: a 10-year study.
Finger PT; Chin KJ; Semenova EA
Eur J Ophthalmol; 2016; 26(1):60-6. PubMed ID: 26391167
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal anti-VEGF bevacizumab (Avastin) for external beam related radiation retinopathy.
Finger PT; Mukkamala SK
Eur J Ophthalmol; 2011; 21(4):446-51. PubMed ID: 21218391
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal bevacizumab at 4-month intervals for prevention of macular edema after plaque radiotherapy of uveal melanoma.
Shah SU; Shields CL; Bianciotto CG; Iturralde J; Al-Dahmash SA; Say EAT; Badal J; Mashayekhi A; Shields JA
Ophthalmology; 2014 Jan; 121(1):269-275. PubMed ID: 24139123
[TBL] [Abstract][Full Text] [Related]
4. Anti-vascular endothelial growth factor bevacizumab (avastin) for radiation retinopathy.
Finger PT; Chin K
Arch Ophthalmol; 2007 Jun; 125(6):751-6. PubMed ID: 17562985
[TBL] [Abstract][Full Text] [Related]
5. High-dose (2.0 mg) intravitreal ranibizumab for recalcitrant radiation retinopathy.
Finger PT; Chin KJ
Eur J Ophthalmol; 2013; 23(6):850-6. PubMed ID: 23813109
[TBL] [Abstract][Full Text] [Related]
6. Monthly intravitreal bevacizumab for macular edema after iodine-125 plaque radiotherapy of uveal melanoma.
Mashayekhi A; Rojanaporn D; Al-Dahmash S; Shields CL; Shields JA
Eur J Ophthalmol; 2014; 24(2):228-34. PubMed ID: 23934823
[TBL] [Abstract][Full Text] [Related]
7. INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT AT 2-MONTH INTERVALS REDUCES FOVEAL AVASCULAR ZONE ENLARGEMENT AND VISION LOSS IN RADIATION MACULOPATHY: A Pilot Study.
Daruich A; Matet A; Schalenbourg A; Zografos L
Retina; 2019 Aug; 39(8):1519-1526. PubMed ID: 29746413
[TBL] [Abstract][Full Text] [Related]
8. Randomized Trial of Monthly Versus As-Needed Intravitreal Ranibizumab for Radiation Retinopathy-Related Macular Edema: 1-Year Outcomes.
Schefler AC; Fuller D; Anand R; Fuller T; Moore C; Munoz J; Kim RS;
Am J Ophthalmol; 2020 Aug; 216():165-173. PubMed ID: 32278771
[TBL] [Abstract][Full Text] [Related]
9. Treatment of radiation maculopathy with intravitreal injection of bevacizumab (Avastin).
Gupta A; Muecke JS
Retina; 2008; 28(7):964-8. PubMed ID: 18698298
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal bevacizumab treatment for radiation macular edema after plaque radiotherapy for choroidal melanoma.
Mason JO; Albert MA; Persaud TO; Vail RS
Retina; 2007 Sep; 27(7):903-7. PubMed ID: 17891015
[TBL] [Abstract][Full Text] [Related]
11. Aflibercept for Radiation Maculopathy Study: A Prospective, Randomized Clinical Study.
Murray TG; Latiff A; Villegas VM; Gold AS
Ophthalmol Retina; 2019 Jul; 3(7):561-566. PubMed ID: 31277797
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic Intravitreal Bevacizumab After Plaque Radiotherapy for Uveal Melanoma: Analysis of Visual Acuity, Tumor Response, and Radiation Complications in 1131 Eyes Based on Patient Age.
Chang M; Dalvin LA; Mazloumi M; Martin A; Yaghy A; Yang X; Bakhtiari S; Li L; Jennings E; Mashayekhi A; Shields CL
Asia Pac J Ophthalmol (Phila); 2020; 9(1):29-38. PubMed ID: 31990743
[TBL] [Abstract][Full Text] [Related]
13. The variable efficacy of intravitreal bevacizumab and triamcinolone acetonide for cystoid macular edema due to radiation retinopathy.
Bakri SJ; Larson TA
Semin Ophthalmol; 2015 Jul; 30(4):276-80. PubMed ID: 24251435
[TBL] [Abstract][Full Text] [Related]
14. Radiation maculopathy treated with intravitreal bevacizumab.
Sánchez-Vicente JL; Muñoz-Morales A; Galván-Carrasco MP; Castilla-Lázpita A; Vital-Berral C; Alfaro-Juárez A; Rueda-Rueda T
Arch Soc Esp Oftalmol; 2017 Jun; 92(6):283-286. PubMed ID: 27894518
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal triamcinolone acetate for radiation maculopathy recalcitrant to high-dose intravitreal bevacizumab.
Kaplan RI; Chaugule SS; Finger PT
Br J Ophthalmol; 2017 Dec; 101(12):1694-1698. PubMed ID: 28416492
[TBL] [Abstract][Full Text] [Related]
16. Ozurdex(®) reduces the retinal thickness in radiation maculopathy refractory to bevacizumab.
Tarmann L; Langmann G; Mayer C; Weger M; Haas A; Wackernagel W
Acta Ophthalmol; 2014 Dec; 92(8):e694-6. PubMed ID: 24739457
[No Abstract] [Full Text] [Related]
17. INTRAVITREAL DEXAMETHASONE IMPLANT FOR RADIATION MACULOPATHY SECONDARY TO PLAQUE BRACHYTHERAPY IN CHOROIDAL MELANOMA.
Caminal JM; Flores-Moreno I; Arias L; Gutiérrez C; Piulats JM; Català J; Rubio MJ; Cobos E; García P; Pera J; Giralt J; Arruga J
Retina; 2015 Sep; 35(9):1890-7. PubMed ID: 26035401
[TBL] [Abstract][Full Text] [Related]
18. DEXAMETHASONE INTRAVITREAL IMPLANT VS RANIBIZUMAB IN THE TREATMENT OF MACULAR EDEMA SECONDARY TO BRACHYTHERAPY FOR CHOROIDAL MELANOMA.
Russo A; Reibaldi M; Avitabile T; Uva MG; Franco LM; Gagliano C; Bonfiglio V; Spatola C; Privitera G; Longo A
Retina; 2018 Apr; 38(4):788-794. PubMed ID: 28272283
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal triamcinolone acetonide for radiation maculopathy after plaque radiotherapy for choroidal melanoma.
Shields CL; Demirci H; Dai V; Marr BP; Mashayekhi A; Materin MA; Manquez ME; Shields JA
Retina; 2005; 25(7):868-74. PubMed ID: 16205566
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal triamcinolone acetonide for acute radiation papillopathy.
Shields CL; Demirci H; Marr BP; Mashayekhi A; Dai VV; Materin MA; Shields JA
Retina; 2006; 26(5):537-44. PubMed ID: 16770260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
